Differential regulation of type IV collagenases and metalloelastase in murine macrophages by the synthetic bacterial lipopeptide JBT 3002

International Journal of Immunopharmacology

Volumn 22, Issue 6, 2000, Pages 431-443

  Kumar, Rakesh ^a   Xie, Keping ^a   Eue, Ines ^a   Dong, Zhongyun ^a   Killion, Jerald J ^a   Fidler, Isaiah J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Lipopeptide; Macrophages; Metalloelastase; Metalloproteinases

Indexed keywords

ELASTASE; GAMMA INTERFERON; GELATINASE A; GELATINASE B; LIPOPEPTIDE; MATRIX METALLOPROTEINASE; N(G) METHYLARGININE; NITRIC OXIDE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ENZYME SYNTHESIS; FEMALE; GENE EXPRESSION REGULATION; MACROPHAGE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0034113374     PISSN: 01920561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0192-0561(00)00008-4     Document Type: Article

References (51)

1. Matrisian L.M. The matrix-degrading metalloproteinases. Bioassays. 14:1992;455-463.
2. Werb Z., Tremble P., Damsky C.H. Regulation of extracellular matrix-degradation by cell-extracellular matrix interactions. Cell Differen. Dev. 32:1990;299-306.
3. Dean D.D., Martel-Pelleier J., Pelleter J.P., Howell D.S., Woessner J.F. Jr. Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. J. Clin. Invest. 84:1989;678-685.
4. Henney A.M., Wakeley P.R., Davies M.J., Foster K., Hembry R., Murphy G., et al. Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc. Natl. Acad. Sci. USA. 88:1992;8154-8158.
5. Hautamaki R.D., Kobayashi D.K., Senior R.M., Shapiro S.D. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science. 277:1997;2002-2004.
6. Mignatti P., Robbins E., Rifkin D.B. Tumor invasion through the human amniotic membrane: requirement for a proteinase cascade. Cell. 47:1986;487-498.
7. Basset P., Bellocq J.P., Wolf C., Stoll I., Limacher J.M., Podhajeer O.L., et al. A novel metalloproteinase gene specifically expressed: stromal cells of breast carcinoma. Nature. 348:1990;699-704.
8. Woessner J.F. Jr. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 5:1991;2145-2154.
9. Cury J.D., Campbell E.J., Lazarus C.J., Albin R.J., Welgus H.G. Selective upregulation of human alveolar macrophage collagenase production by lipopolysaccharide and comparison to collagenase production by fibroblasts. J. Immunol. 141:1988;4306-4312.
10. Welgus H.G., Campbell E.J., Curry J.D., Eisen A.Z., Senior R.M., Wilhelm S.M. Neutral metalloproteinases produced by human mononuclear phagocytes: enzyme profile, regulation, and expression during cellular development. J. Clin. Invest. 86:1990;1496-1502.
11. Campbell E.J., Cury J.D., Lazarus C.J., Welgus H.G. Monocyte procollagenase and tissue inhibitor of metalloproteinase: identification, characterization, and regulation of secretion. J. Biol. Chem. 262:1987;15862-15868.
12. Xie B., Dong Z., Fidler I.J. Regulatory mechanisms for the expression of type IV collagenases/gelatinases in murine macrophages. J. Immunol. 152:1994;3637-3644.
13. Hibbs M.S., Hoidal J.R., Kang A.J. Expression of a metalloproteinase that degrades native type V collagen and denatured collagens by cultured human alveolar macrophages. J. Clin. Invest. 80:1987;1644-1650.
14. Denhardt D.T., Feng B., Edwards D.R., Cocuzzi E.T., Malayanka U.M. Tissue inhibitor of metalloproteinases (TIMP, aka EPA): structure, control of expression and biological functions. Pharmacol. Ther. 59:1993;329-341.
15. Kumar R., Dong Z., Fidler I.J. Differential regulation of metalloelastase activity in murine peritoneal macrophages by granulocyte-macrophage colony-stimulating factor and macrophage colony-stimulating factor. J. Immunol. 157:1996;5104-5111.
16. Werb Z., Gordon S. Elastase secretion by stimulated macrophages: characterization and regulation. J. Exp. Med. 142:1975;361-377.
17. Shapiro S.D., Kobayashi D.K., Welgus H.G. Identification of TIMP-2 in human alveolar macrophages. Regulation of biosynthesis is opposite to that of metalloproteinases and TIMP-1. J. Biol. Chem. 267:1992;13890-13894.
18. Welgus H.G., Senior R.M., Parks W.C., Kahn A.J., Ley T.J., Shapiro S.D., et al. Neutral proteinase expression by human mononuclear phagocytes: a prominent role of cellular differentiation. Matrix (suppl.). 1:1992;363-367.
19. Harris E.D. Jr, Welgus H.G., Krane S.M. Regulation of mammalian collagenases. Collagen Related Res. 4:1984;493-512.
20. Salo T., Turpeenniemi-Hujanen T., Tryggvason K. Tumor-promoting phorbol esters and cell proliferation stimulate secretion of basement membrane (type IV) collagen-degrading metalloproteinases by human fibroblasts. J. Biol. Chem. 260:1985;8526-8531.
21. Cottam D.W., Rees R.C. Regulation of matrix metalloproteinases: their role in tumor invasion and metastasis. Int. J. Oncol. 2:1993;861-869.
22. Saren P., Welgus H.G., Kovanen P.T. TNF-α and IL-β selectively induce expression of 92-kDa gelatinase by human macrophages. J. Immunol. 157:1996;4159-4165.
23. Shapiro S.D., Campbell E.J., Kobayashi D.K., Welgus H.G. Immune modulation of metalloproteinase production in human macrophages. Selective pretranslational suppression of interstitial collagenase and stromelysin biosynthesis by interferon-γ J. Clin. Invest. 86:1990;1204-1210.
24. Miltenburg A.M., Lacraz S., Welgus H.G., Dayer J.-M. Immobilized anti-CD3 antibody activates T cell clones to induce the production of interstitial collagenase, but not tissue inhibitor of metalloproteinases, in monocyte THP-1 cells and dermal fibroblasts. J. Immunol. 154:1995;2655-2667.
25. Lacraz S., Isler P., Vey E., Welgus H.G., Dayer J.-M. Direct contact between T lymphocytes and monocytes is a major pathway for induction of metalloproteinase expression. J. Biol. Chem. 269:1994;22027-22033.
26. Busiek D.F., Baragi V., Nehring L.C., Parks W.C., Welgus H.G. Matrilysin expression by human mononuclear phagocytes and its regulation by cytokines and hormones. J. Immunol. 154:1995;6484-6491.
27. 2 synthesis blocks interstitial collagenase and 92-kDa type IV collagenase/gelatinase production by human monocytes. J. Biol. Chem. 267:1992;515-519.
28. Mertz P.M., DeWitt D.L., Stetler-Stevenson W.G., Wahl L.M. Interleukin 10 suppression of monocyte prostaglandin H synthase-2: mechanism of inhibition of prostaglandin-dependent matrix metalloproteinase production. J. Biol. Chem. 269:1994;21322-21329.
29. Wahl L.M., Corcoran M.L., Mergenhagen S.E., Finbloom D.S. Inhibition of phospholipase activity in human monocytes by IFN-γ blocks endogenous prostaglandin E2-dependent collagenase production. J. Immunol. 144:1990;3518-3522.
30. Lacraz S., Nicod L.P., Chicheportiche R., Welgus H.G., Dayer J.-M. IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes. J. Clin. Invest. 96:1995;2304-2310.
31. Lotz M., Guerne P.-A. Interleukin-6 induces the synthesis of tissue inhibitor of metalloproteinase-1/erythroid potentiating activity (TIMP-1/EPA). J. Biol. Chem. 266:1991;2017-2020.
32. Shapiro S.D., Kobayashi D.K., Pentland A.P., Welgus H.G. Induction of macrophage metalloproteinases by extracellular matrix: evidence for enzyme- and substrate-specific responses involving prostaglandin-dependent mechanisms. J. Biol. Chem. 268:1993;8170-8175.
33. Corcoran M.L., Kibbey M.C., Kleinman H.K., Wahl L.M. Laminin SIKVAV peptide induction of monocyte/macrophage prostaglandin E2 and matrix metalloproteinases. J. Biol. Chem. 270:1995;10365-10368.
34. 2 by human blood monocytes subsequent to interaction with different bacterial derived agents. Lymphokine Res. 9:1990;449-454.
35. Utsugi T., Nii A., Fan D., Pak C., Denkins Y., van Hoogevest P., et al. Comparative efficacy of liposomes containing synthetic bacterial cell wall analogues for tumoricidal activation of monocytes and macrophages. Cancer Immunol. Immunother. 33:1991;285-292.
36. Utsugi T., Dinney C.P.N., Killion J.J., Fidler I.J. In situ activation of mouse macrophages and therapy of spontaneous renal cell cancer metastasis by liposomes containing the lipopeptide CGP 31362. Cancer Immunol. Immunother. 33:1991;375-381.
37. Nii A., Utsugi T., Fan D., Denkins Y., Pak C., Brown D., et al. Optimization of the liposomes encapsulating a new lipopeptide CGP 31362 for efficient activation of tumoricidal properties in monocytes and macrophages. J. Immunother. 10:1991;236-246.
38. Eue I., Kumar R., Dong Z., Killion J.J., Fidler I.J. Induction of nitric oxide production and tumoricidal properties in murine macrophages by a new synthetic lipopeptide JBT 3002 encapsulated in liposomes. J. Immunother. 21:1998;340-351.
39. Kumar R., Eue I., Dong Z., Killion J.J., Fidler I.J. Expression of inflammatory cytokines by murine macrophages activated with a new synthetic lipopeptide JBT 3002. Cancer Biother. Radiopharmacol. 12:1997;333-340.
40. Dong Z., Killion J.J., Kumar R., Eue I., Yang X., Lu W., et al. Activation of cytokine production and tumoricidal properties in human monocytes by a new synthetic lipopeptide JBT 3002 is independent of binding to serum LPS-binding protein and CD14. J. Leukoc. Biol. 63:1998;766-774.
41. MacMiking J.D., Nathan C., Hom G., et al. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell. 81:1995;641-650.
42. Schroit A.J., Fidler I.J. Effects of liposome structure and lipid composition on the activation of the tumoricidal properties of macrophages by liposomes containing muramyl dipeptide. Cancer Res. 42:1982;161-167.
43. Saiki I., Fidler I.J. Synergistic activation by recombinant mouse IFN-γ and muramyl dipeptide of tumoricidal properties in mouse macrophages. J. Immunol. 135:1985;684-688.
44. Birkedal-Hansen H., Taylor R.E. Detergent activation of latent collagenase and resolution of its component molecules. Biochem. Biophys. Res. Commun. 107:1982;1173-1178.
45. Ding A., Sanchez E., Nathan C.F. Taxol shares the ability of bacterial lipopolysaccharide to induce tyrosine phosphorylation of microtubule-associated protein kinase. J. Immunol. 151:1993;5596-5602.
46. Dayer J.M., de Rochemonteix B., Burrus B., Demczuk S., Dinarello C.A. Human recombinant interleukin-1 stimulates collagenase and prostaglandin E2 production by human synovial cells. J. Clin. Invest. 77:1986;645-648.
47. Dayer J.M., Beutler B., Cerami A. Cachectin tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts. J. Exp. Med. 162:1985;2163-2168.
48. Mizel S.B., Dayer J.M., Krane S.M., Mergenhagen S.E. Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte-activating factor (interleukin-1). Proc. Natl. Acad. Sci. USA. 78:1981;2474-2477.
49. Yu S.F., Koerner T.J., Adams D.O. Gene regulation in macrophage activation: differential regulation of genes encoding for tumor necrosis factor, interleukin-1. JE and KC by interferon-γ and lipopolysaccharide. J. Leukoc. Biol. 48:1990;412-419.
50. Nathan C. Nitric oxide as a secretary product of mammalian cells. FASEB J. 6:1992;3051-3064.
51. Sheffler L.A., Wink D.A., Melillo G., Cox G.W. Characterization of nitric oxide-stimulated ADP-ribosylation of various proteins from the mouse macrophage cell line ANA-1 using sodium nitroprusside and the novel nitric oxide-donating compound diethylamine dinitric oxide. J. Leukoc. Biol. 57:1995;152-159.